GEN Exclusives

More »

GEN News Highlights

More »
Oct 16, 2006

Arbor Vita and NoNO Collaborate on Stroke Treatment

  • Arbor Vita and NoNO partnered to develop and commercialize drugs for the treatment of stroke. The R&D collaboration combines Arbor Vita’s PDZ-based drug discovery platform with NoNO’s expertise in the area of neurological disorders.

    “Under this collaboration, we are developing drugs targeting PDZ-protein interactions to mitigate brain damage from cerebral ischemia, which could also extend to the treatment of neurotrauma, pain, Alzheimer’s, and other diseases,” states Peter Lu, M.D., founder, president, and CEO of Arbor Vita.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?